NO20022811D0 - Benzosyreestere av oksazolidinoner med en hydroksyacetylpiperazinsubstituent - Google Patents

Benzosyreestere av oksazolidinoner med en hydroksyacetylpiperazinsubstituent

Info

Publication number
NO20022811D0
NO20022811D0 NO20022811A NO20022811A NO20022811D0 NO 20022811 D0 NO20022811 D0 NO 20022811D0 NO 20022811 A NO20022811 A NO 20022811A NO 20022811 A NO20022811 A NO 20022811A NO 20022811 D0 NO20022811 D0 NO 20022811D0
Authority
NO
Norway
Prior art keywords
oxazolidinones
benzoic acid
acid esters
hydroxyacetylpiperazine
substituent
Prior art date
Application number
NO20022811A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022811L (no
Inventor
Jr Jackson B Hester
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO20022811D0 publication Critical patent/NO20022811D0/no
Publication of NO20022811L publication Critical patent/NO20022811L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20022811A 1999-12-14 2002-06-13 Benzosyreestere av oksazolidinoner med en hydroksyacetylpiperazinsubstituent NO20022811L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17067599P 1999-12-14 1999-12-14
PCT/US2000/032432 WO2001044212A1 (en) 1999-12-14 2000-12-06 Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent

Publications (2)

Publication Number Publication Date
NO20022811D0 true NO20022811D0 (no) 2002-06-13
NO20022811L NO20022811L (no) 2002-06-13

Family

ID=22620832

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022811A NO20022811L (no) 1999-12-14 2002-06-13 Benzosyreestere av oksazolidinoner med en hydroksyacetylpiperazinsubstituent

Country Status (26)

Country Link
US (1) US6281210B1 (pt)
EP (1) EP1242395B1 (pt)
JP (1) JP2003516977A (pt)
KR (1) KR20020062332A (pt)
CN (1) CN1390211A (pt)
AR (1) AR026547A1 (pt)
AT (1) ATE288423T1 (pt)
AU (1) AU1805801A (pt)
BR (1) BR0015177A (pt)
CA (1) CA2387047A1 (pt)
CO (1) CO5261527A1 (pt)
CZ (1) CZ20022389A3 (pt)
DE (1) DE60017941T2 (pt)
EA (1) EA200200673A1 (pt)
ES (1) ES2236006T3 (pt)
HU (1) HUP0203787A3 (pt)
IL (1) IL150031A0 (pt)
MX (1) MXPA02005909A (pt)
NO (1) NO20022811L (pt)
PE (1) PE20010851A1 (pt)
PL (1) PL355369A1 (pt)
PT (1) PT1242395E (pt)
SK (1) SK5972002A3 (pt)
TW (1) TW544449B (pt)
WO (1) WO2001044212A1 (pt)
ZA (1) ZA200202953B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
ES2256318T3 (es) * 2000-10-17 2006-07-16 PHARMACIA & UPJOHN COMPANY LLC Metodos de produccion de compuestos de oxazolidinona.
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
TW200403240A (en) * 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents
TW200404069A (en) * 2002-06-28 2004-03-16 Upjohn Co Difluorothioacetamides of oxazolidinones with a glycoloylpiperazine substituent
DE60309504T2 (de) * 2002-11-21 2007-05-16 Pharmacia & Upjohn Co. Llc, Kalamazoo N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinon-5-carbosäureamid-derivate und verwandte verbindungen als antibakterielle mittel
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005045518A1 (de) * 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
AU2006299126B2 (en) 2005-10-04 2012-06-28 Bayer Intellectual Property Gmbh Novel polymorphous form and the amorphous form of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
US20100210602A1 (en) * 2006-12-12 2010-08-19 The Johns Hopkins University PhoU (PerF), A PERSISTENCE SWITCH INVOLVED IN PERSISTER FORMATION AND TOLERANCE TO MULTIPLE ANTIBIOTICS AND STRESSES AS A DRUG TARGET FOR PERSISTER BACTERIA
EP2170874A4 (en) * 2007-06-22 2011-08-31 Orchid Res Lab Ltd NEW COMPOUNDS AND THEIR USE

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100312903B1 (ko) * 1993-11-22 2002-02-28 로렌스 티. 마이젠헬더 치환된-하이드록시아세틸피페라진페닐옥사졸리디논의에스테르
MY116093A (en) * 1996-02-26 2003-11-28 Upjohn Co Azolyl piperazinyl phenyl oxazolidinone antimicrobials
NZ501412A (en) * 1997-05-30 2001-11-30 Upjohn Co Oxazolidinone antibacterial agents having a thiocarbonyl functionality
GB9812019D0 (en) * 1998-06-05 1998-07-29 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
EA200200673A1 (ru) 2002-12-26
CO5261527A1 (es) 2003-03-31
PE20010851A1 (es) 2001-08-17
TW544449B (en) 2003-08-01
BR0015177A (pt) 2002-06-18
ZA200202953B (en) 2003-09-23
CN1390211A (zh) 2003-01-08
AU1805801A (en) 2001-06-25
US6281210B1 (en) 2001-08-28
DE60017941D1 (de) 2005-03-10
MXPA02005909A (es) 2002-10-23
CA2387047A1 (en) 2001-06-21
ES2236006T3 (es) 2005-07-16
SK5972002A3 (en) 2003-01-09
CZ20022389A3 (cs) 2002-10-16
PT1242395E (pt) 2005-05-31
DE60017941T2 (de) 2006-03-30
JP2003516977A (ja) 2003-05-20
EP1242395A1 (en) 2002-09-25
WO2001044212A1 (en) 2001-06-21
HUP0203787A3 (en) 2005-06-28
AR026547A1 (es) 2003-02-19
IL150031A0 (en) 2002-12-01
EP1242395B1 (en) 2005-02-02
HUP0203787A2 (hu) 2003-07-28
ATE288423T1 (de) 2005-02-15
NO20022811L (no) 2002-06-13
KR20020062332A (ko) 2002-07-25
PL355369A1 (en) 2004-04-19

Similar Documents

Publication Publication Date Title
NO20022811D0 (no) Benzosyreestere av oksazolidinoner med en hydroksyacetylpiperazinsubstituent
NO20020764L (no) Benzosyrederivater for behandling av diabetes mellitus
EE05215B1 (et) Meetod tskloproplkarbokslhappe estrite ja derivaatide valmistamiseks
NO20030249L (no) Oksygenerte estere av 4-jod-fenylamino-benzohydroksamsyrer
ID22013A (id) Senyawa-senyawa ester
IS8231A (is) Lyfjafræðilega gagnleg sölt karboxýlsýruafleiða
DE50212761D1 (de) Neuartige aminodicarbonsäurederivate
FI954007A (fi) Substituoitujen 4-fenyyli-6-amino-nikotiinihappojohdannaisten käyttö lääkeaineena
DE60043730D1 (de) Arylsulfonamid-substituierte hydroxamsäure-derivate
IS8232A (is) Lyfjafræðilega gagnleg sölt karboxýlsýruafleiða
DE50005284D1 (de) Substituierte n-benzyl-indol-3-yl- glyoxylsäure-derivate mit antitumorwirkung
FR2796732B1 (fr) Piece d'horlogerie a affichage du quantieme
NO20015368D0 (no) Anvendelse av forbindelser omfattende en nitrogen-oksygen- heteroring
NO20021368L (no) Fremgangsmåte for fremstilling av fenyleddiksyre derivater
DE60143052D1 (de) Lipid vom carbonsäuretyp
NO20021043L (no) Mellomprodukter for fremstilling av kinolonkarboksylsyre- derivater
DK1242395T3 (da) Benzoesyreestere af oxazolidinoner med en hydroxyacetylpiperazinsubstituent
NO20013857D0 (no) Krystallinsk form av Eplerenon
EE200100381A (et) Morfolinobensamiidi uued soolad
DE60010725T2 (de) Herstellung von arylcarbonsäureestern
ATE335747T1 (de) Kristallines 3-cephem derivat
ATE394098T1 (de) Wirkstoffsalze und ester von 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-p ntan-3-ol und 3-(3- dimethylamino-1-ethyl-1-hydroxy-2-methyl-propyl - phenol
NO20013537L (no) Krystallpolymorfisme av aminoetylfenoksyeddiksyre derivater
EE200200392A (et) Meetod arüüliminometüülkarbamiinhappeestrite valmistamiseks
DE69809692D1 (de) Herstellung von Carbonsäureestern

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application